JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4031 Telaprevir (VX-950)
1 Citation

Target: HCV NS3-4A protease

Summary: HCV NS3-4A protease inhibitor

≥32.95 mg/mL
A4095 Pracinostat (SB939)
2 Citation

Target: Histone Deacetylases (HDACs)

Summary: Pan-HDAC inhibitor

insoluble in H2O; ≥11.4 mg/mL
A4119 AMG-900

Summary: Aurora kinase inhibitor

≥25.2 mg/mL
A4234 TW-37
1 Citation

Target: Bcl-2|Bcl-xl|Mcl-1

Summary: Bcl-2 inhibitor, inhibits Bcl-2,Bcl-XL and Mcl-1

insoluble in H2O; ≥19.75 mg/mL
A4307 GW0742

Summary: PPARδ/β agonist,potent and selective

≥47.1 mg/mL
A4329 Cilomilast

Target: Phosphodiesterases (PDEs)

Summary: Potent PDE4 inhibitor

insoluble in H2O; ≥12.95 mg/mL
A3177 AN-2690
1 Citation

Target: Antifungal

Summary: Antifungal agent

≥3.72 mg/mL
A3331 CP-809101 hydrochloride

Summary: 5-HT2C receptor agonist, potent and selective

Soluble in DMSO
A3397 Erlotinib
6 Citation

Summary: EGFR tyrosine kinase inhibitor

insoluble in H2O; ≥19.65 mg/mL
A3432 GDC-0941 dimethanesulfonate

Summary: PI3K inhibitor

insoluble in H2O; insoluble in EtOH; ≥207.6 mg/mL